Weight regain after stopping GLP-1 receptor agonists—including orforglipron (Foundayo)—is a well-documented phenomenon because obesity is generally considered a chronic, progressive condition. The Reality of Weight RegainWhen you stop taking these more info medications, you are essentially removing the physiological "brakes" on your appetite. Without the medication to regulate GLP-1 receptors, your body's natural hunger hormones often return to their previous levels, leading to an increase in appetite and the return of "food noise" (persistent thoughts about food). Clinical Observations: Studies across the GLP-1 class (including semaglutide and tirzepatide) show that many patients regain a significant portion of their lost weight within the first year of cessation. Research indicates that patients may regain, on average, two-thirds of their lost weight within 12 months of stopping.